Connect Biopharma Holdings Limited
CNTBNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $56.99M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.85$3.82
- Volume (live)
- -
- Avg. volume (3M)
- 7.47M
Connect Biopharma Holdings (CNTB) Stock Price & Financial Analysis
Connect Biopharma Holdings Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.87 - $0.91 |
|---|---|
| 52-Week High | $3.82 |
| 52-Week Low | $0.85 |
| Open | $0.89 |
| Volume (last close) | 570.33K |
| Average Volume (3M) | 7.47M |
| Revenue (TTM) | 2.95M |
|---|---|
| Net Income (TTM) | -66.90M |
| Free Cash Flow (TTM) | -54.48M |
| EPS (TTM) | −$1.16 |
| Profit Margin | -2265.49% |
| Operating Margin | -2311.65% |
| Return on Equity (ROE) | -249.06% |
| Debt to Equity | 0.02 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 56.99M |
|---|---|
| Shares Outstanding | 62.88M |
| Price to Sales (P/S) | 19.30 |
| Price to Book (P/B) | 2.12 |
| EV/EBITDA | -0.46 |
| 50-Day MA | $1.72 |
|---|---|
| 200-Day MA | $2.29 |
| 1-Year Change | −47.62% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Connect Biopharma Holdings at a Glance
As of the Oct 16, 2026 close, Connect Biopharma Holdings (CNTB) has a market capitalization of $56.99M. The stock trades at 19.3× sales. Over the trailing twelve months it lost $66.90M on revenue of $2.95M and burned $54.48M of free cash flow. Revenue grew 10.9% year over year.
As of its latest reported balance sheet, it holds $27.02M in cash and securities against $596.00K of debt, a net cash position of $26.42M.
Connect Biopharma Holdings does not currently pay a dividend.
The share price is down 47.6% over the past year. At $0.91 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.85 to $3.82, below its 200-day moving average of $2.29.
Based on 7 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $6.86, 656.9% above the Oct 16, 2026 close.
Frequently Asked Questions About Connect Biopharma Holdings
What is the current stock price for CNTB?
As of the Oct 16, 2026 close, CNTB stock trades at $0.91. The 52-week range is $0.85–$3.82, with a day range of $0.87–$0.91.
What is the P/E ratio for CNTB?
The P/E ratio (Price-to-Earnings) for CNTB is shown in the Key Statistics section. This valuation metric helps compare Connect Biopharma Holdings Limited to industry peers.
Does CNTB pay dividends?
Connect Biopharma Holdings does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CNTB?
Based on ratings from 7 professional analysts over the last 90 days, the consensus for CNTB is Buy. The average 12-month price target is $6.86, a 656.9% upside from the Oct 16, 2026 close of $0.91.
What is the market cap of CNTB?
As of the Oct 16, 2026 close, Connect Biopharma Holdings's market capitalization is $57.0M, classifying it as a micro-cap company. Connect Biopharma Holdings operates in the Healthcare sector within the Biotechnology industry.